Clinical implications of aldosterone blockade

This publication has 29 references indexed in Scilit:

• Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
  Journal of the American College of Cardiology, 2001
• Cardiovascular Mortality in Hypertensive Men According to Presence of Associated Risk Factors
  Hypertension, 2001
• Recent studies with eplerenone, a novel selective aldosterone receptor antagonist
  Current Opinion in Pharmacology, 2001
• Aldosterone: A Mediator of Myocardial Necrosis and Renal Arteriopathy*
  Endocrinology, 2000
• Aldosterone and vascular damage
  Current Hypertension Reports, 2000
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Blood Pressure as a Cardiovascular Risk Factor
  JAMA, 1996
• Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease
  The American Journal of Cardiology, 1995
• Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension
  The American Journal of Cardiology, 1993
• Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
  Circulation, 1991